NCT07351435Not yet recruiting
The Caribbean Registry of Extracorporeal Membrane Oxygenation (ECMO) From the University Hospital in Martinique
Source: ClinicalTrials.gov · Last updated 20 Jan 2026
Brief summary (registry, in English)
The project's main goal is to collect baseline clinical and procedural data as well as to assess clinical outcomes for all patients undergoing VV, VA or VAV ECMO implantation in the French West Indies and Guiana. All patients undergoing ECMO implantation will be prospectively registered.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 1200 (estimated)
- First submitted
- 18 Nov 2025
- Start date
- 1 Feb 2026
- Primary completion date
- 31 Dec 2032
- Lead sponsor
- University of Genova
- Diseases
- Heart failure
- NCT number
- NCT07351435
What you commit to
- Study type: Observational
- Planned participants: 1200
- From 1 Feb 2026 to the primary completion date, 31 Dec 2032
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients with incomplete data (primary endpoint and less than 80% secondary study outcomes)
Who the study is looking for
- All consecutive patients implanted with a veno-venous extracorporeal membrane oxygenation device or extracorporeal membrane oxygenation device by the HeartTeam from the University Hospital of Martinique (UHM) from January 2010
Age in the registry: - to 90 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.